Figure 4 | Scientific Reports

Figure 4

From: Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort

Figure 4

Urine p75ECD levels and ALS-severity and progression. (A) There was significant difference among three clinical stages; (B) There were no differences in urine p75ECD concentrations among ALS patients with different onset regions; (C) There was negative correlation between baseline p75ECD and ALSFRS-r scores in ALS patients; (D) Significantly higher urine p75ECD concentrations were detected in the fast-progression group than in the slow-progression group.

Back to article page